Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurie Menger

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|March 2, 2012
[Contributions of immunogenic cell death to the efficacy of anticancer chemotherapy]G Kroemer, Sandy Adjemian, Mickaël Michaud, et al.
Oncoimmunology|December 25, 2012
Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effectsOliver Kepp, Laurie Menger, Erika Vacchelli, et al.
Cancer Research|May 20, 2016
TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established TumorsLaurie Menger, Anna Sledzinska, Katharina Bergerhoff, et al.
Autophagy|February 25, 2012
Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell deathIsabelle Martins, Mickaël Michaud, Abdul Qader Sukkurwala, et al.
Cytokine & Growth Factor Reviews|June 22, 2013
Crosstalk between ER stress and immunogenic cell deathOliver Kepp, Laurie Menger, Erika Vacchelli, et al.
The Journal of Experimental Medicine|December 7, 2018
A common transcriptomic program acquired in the thymus defines tissue residency of MAIT and NKT subsetsMarion Salou, François Legoux, Jules Gilet, et al.
Blood|October 29, 2015
TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cellsLaurie Menger, Agnes Gouble, Maria A V Marzolini, et al.
Nature Cancer|May 29, 2023
Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4<sup>+</sup> CAR T-cell antitumor activityMorgane Boulch, Marine Cazaux, Alexis Cuffel, et al.
Science Immunology|December 3, 2021
In vivo genome-wide CRISPR screens identify SOCS1 as intrinsic checkpoint of CD4<sup>+</sup> T<sub>H</sub>1 cell responseAurélien Sutra Del Galy, Silvia Menegatti, Jaime Fuentealba, et al.
Oncoimmunology|June 28, 2012
Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancerErika Vacchelli, Lorenzo Galluzzi, Vanessa Rousseau, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|March 2, 2012
[Contributions of immunogenic cell death to the efficacy of anticancer chemotherapy]G Kroemer, Sandy Adjemian, Mickaël Michaud, et al.
Oncoimmunology|December 25, 2012
Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effectsOliver Kepp, Laurie Menger, Erika Vacchelli, et al.
Cancer Research|May 20, 2016
TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established TumorsLaurie Menger, Anna Sledzinska, Katharina Bergerhoff, et al.
Autophagy|February 25, 2012
Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell deathIsabelle Martins, Mickaël Michaud, Abdul Qader Sukkurwala, et al.
Cytokine & Growth Factor Reviews|June 22, 2013
Crosstalk between ER stress and immunogenic cell deathOliver Kepp, Laurie Menger, Erika Vacchelli, et al.
The Journal of Experimental Medicine|December 7, 2018
A common transcriptomic program acquired in the thymus defines tissue residency of MAIT and NKT subsetsMarion Salou, François Legoux, Jules Gilet, et al.
Blood|October 29, 2015
TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cellsLaurie Menger, Agnes Gouble, Maria A V Marzolini, et al.
Nature Cancer|May 29, 2023
Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4<sup>+</sup> CAR T-cell antitumor activityMorgane Boulch, Marine Cazaux, Alexis Cuffel, et al.
Science Immunology|December 3, 2021
In vivo genome-wide CRISPR screens identify SOCS1 as intrinsic checkpoint of CD4<sup>+</sup> T<sub>H</sub>1 cell responseAurélien Sutra Del Galy, Silvia Menegatti, Jaime Fuentealba, et al.
Oncoimmunology|June 28, 2012
Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancerErika Vacchelli, Lorenzo Galluzzi, Vanessa Rousseau, et al.
Pageof 3